Printer Friendly

BARR REINTRODUCES E.S.P.

 POMONA, N.Y., May 19 /PRNewswire/ -- Barr Laboratories, Inc. (AMEX: BRL) announced the reintroduction of all package sizes of its popular antibiotic, E.S.P.(TM) a generic equivalent to Ross Laboratories' Pediazole(R). Barr will begin shipping E.S.P. immediately.
 Barr Laboratories was the first generic manufacturer to introduce a product equivalent to Pediazole in 1988. On a full-year basis, E.S.P. will increase the company's current sales by approximately 30 percent.
 E.S.P. was one of 24 products temporarily suspended earlier this year by the Federal District Court in New Jersey. The court required completion of additional validation prior to reintroduction of the suspended products. Barr and the FDA agree that the additional studies completed for E.S.P. satisfy the requirements of the order. The company is preparing additional validation studies on the remaining suspended products.
 "E.S.P. is an important product to Barr and American consumers and we are pleased to announce its reintroduction," said Bruce Downey, president, Barr Laboratories. "We continue to work with FDA and expect reintroduction of other products over the next several weeks."
 -0- 5/19/93
 /CONTACT: Harold Cohen of Barr Laboratories, 914-362-2823/
 (BRL)


CO: Barr Laboratories, Inc. ST: New York IN: MTC SU:

SH-PS -- NY028 -- 0214 05/19/93 10:44 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 19, 1993
Words:216
Previous Article:AT&T, YASUDA FIRE AND MARINE INSURANCE CO. CAPTURE TOP HONORS IN EDELMAN AWARD COMPETITION
Next Article:UNITED MEXICAN STATES PESO-DENOMINATED SECURITIES RATED 'AA+' BY DUFF & PHELPS
Topics:


Related Articles
BARR REINTRODUCES THREE ANTIBIOTICS
BARR REINTRODUCES ANTI-ANXIETY DRUG
BARR LABORATORIES RELEASES SALES AND EARNINGS FOR FISCAL YEAR ENDED JUNE 30, 1993
BARR REINTRODUCES ANTI-ANXIETY DRUG
BARR REINTRODUCES ANTI-ANXIETY DRUG
BARR REINTRODUCES ANTI-ANXIETY DRUG
BARR LABORATORIES, FDA SETTLE 1992 COURT CASE; COURT'S ORDER ESTABLISHES PROCESS FOR COMPANY TO REINTRODUCE FORMER PRODUCTS
Barr Reintroduces Generic Demerol 100 mg Tablets; First Product in Company's Revitalized Pain Management Category
Barr Receives Approval for Generic Percocet(R) Tablets
Barr Receives Approval for Demeclocycline Hydrochloride Tablets USP, 150 mg & 300 mg.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters